JP2023512557A5 - - Google Patents

Info

Publication number
JP2023512557A5
JP2023512557A5 JP2022547846A JP2022547846A JP2023512557A5 JP 2023512557 A5 JP2023512557 A5 JP 2023512557A5 JP 2022547846 A JP2022547846 A JP 2022547846A JP 2022547846 A JP2022547846 A JP 2022547846A JP 2023512557 A5 JP2023512557 A5 JP 2023512557A5
Authority
JP
Japan
Prior art keywords
group
substituted
alkyl
formula
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022547846A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023512557A (ja
JP7711073B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/016698 external-priority patent/WO2021158840A1/en
Publication of JP2023512557A publication Critical patent/JP2023512557A/ja
Publication of JP2023512557A5 publication Critical patent/JP2023512557A5/ja
Application granted granted Critical
Publication of JP7711073B2 publication Critical patent/JP7711073B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022547846A 2020-02-06 2021-02-05 免疫抑制剤として有用な大環状pad4阻害剤 Active JP7711073B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062970832P 2020-02-06 2020-02-06
US62/970,832 2020-02-06
PCT/US2021/016698 WO2021158840A1 (en) 2020-02-06 2021-02-05 Macrocyclic pad4 inhibitors useful as immunosuppressant

Publications (3)

Publication Number Publication Date
JP2023512557A JP2023512557A (ja) 2023-03-27
JP2023512557A5 true JP2023512557A5 (cg-RX-API-DMAC10.html) 2024-02-06
JP7711073B2 JP7711073B2 (ja) 2025-07-22

Family

ID=74798090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022547846A Active JP7711073B2 (ja) 2020-02-06 2021-02-05 免疫抑制剤として有用な大環状pad4阻害剤

Country Status (6)

Country Link
US (1) US12492202B2 (cg-RX-API-DMAC10.html)
EP (1) EP4100405A1 (cg-RX-API-DMAC10.html)
JP (1) JP7711073B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220137694A (cg-RX-API-DMAC10.html)
CN (1) CN115298175B (cg-RX-API-DMAC10.html)
WO (1) WO2021158840A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115298175B (zh) 2020-02-06 2024-05-07 百时美施贵宝公司 可用作免疫抑制剂的大环pad4抑制剂
TW202140477A (zh) 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑
MX2022013615A (es) 2020-04-30 2022-11-16 Gilead Sciences Inc Inhibidores de macrociclo de peptidilarginina deiminasas.
EP4267562A1 (en) 2020-12-22 2023-11-01 Gilead Sciences, Inc. Inhibitors of peptidylarginine deiminases
TW202233174A (zh) 2020-12-22 2022-09-01 美商基利科學股份有限公司 肽基精胺酸去亞胺酶之抑制劑
WO2025024265A1 (en) 2023-07-21 2025-01-30 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad4 modulators
WO2026020127A2 (en) 2024-07-19 2026-01-22 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad2 modulators

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2611010C2 (ru) 2012-07-26 2017-02-17 Глаксо Груп Лимитед 2-(Азаиндол-2-ил)бензимидазолы в качестве ингибиторов PAD4
WO2016185279A1 (en) * 2015-05-21 2016-11-24 Glaxosmithkline Intellectual Property Development Limited Benzoimidazole derivatives as pad4 inhibitors
AR107030A1 (es) 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores aza-bencimidazol de pad4
AR107032A1 (es) * 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores bicíclicos de pad4
SG11201807021UA (en) 2016-02-23 2018-09-27 Padlock Therapeutics Inc Heteroaryl inhibitors of pad4
US10703741B2 (en) * 2016-07-27 2020-07-07 Padlock Therapeutics, Inc. Covalent inhibitors of PAD4
KR102502992B1 (ko) 2016-09-12 2023-02-24 패들락 테라퓨틱스, 인코포레이티드 Pad4의 헤테로아릴 억제제
ES2929200T3 (es) 2018-08-08 2022-11-25 Bristol Myers Squibb Co Tienopirroles sustituidos como inhibidores de PAD4
MX2021001471A (es) 2018-08-08 2021-04-28 Bristol Myers Squibb Co Benzimidazoles sustituidos como inhibidores de peptidil arginina deiminasa 4 (pad4).
EP3833440A1 (en) 2018-08-08 2021-06-16 Bristol-Myers Squibb Company Indole and azaindole inhibitors of pad enzymes
ES2956090T3 (es) 2018-08-08 2023-12-13 Bristol Myers Squibb Co Inhibidores de bencimidazol de enzimas PAD
CN115298175B (zh) 2020-02-06 2024-05-07 百时美施贵宝公司 可用作免疫抑制剂的大环pad4抑制剂
TW202140477A (zh) 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑

Similar Documents

Publication Publication Date Title
JP2021534108A5 (cg-RX-API-DMAC10.html)
JP2021534097A5 (cg-RX-API-DMAC10.html)
JP2021534106A5 (cg-RX-API-DMAC10.html)
JP2021534104A5 (cg-RX-API-DMAC10.html)
JP2009543802A5 (cg-RX-API-DMAC10.html)
JP2022501430A5 (cg-RX-API-DMAC10.html)
JP2021532109A5 (cg-RX-API-DMAC10.html)
JP2009535307A5 (cg-RX-API-DMAC10.html)
JP2008510828A5 (cg-RX-API-DMAC10.html)
JP2009523724A5 (cg-RX-API-DMAC10.html)
JP2023509422A5 (cg-RX-API-DMAC10.html)
JP2023539949A5 (cg-RX-API-DMAC10.html)
JP2016508505A5 (cg-RX-API-DMAC10.html)
RU2006134020A (ru) Конденсированные производные пиразола
JP2012507522A5 (cg-RX-API-DMAC10.html)
JP2001510843A5 (cg-RX-API-DMAC10.html)
JP2004524340A5 (cg-RX-API-DMAC10.html)
JP2024526849A5 (cg-RX-API-DMAC10.html)
JP2021519785A5 (cg-RX-API-DMAC10.html)
JP2008535803A5 (cg-RX-API-DMAC10.html)
JP2006504621A5 (cg-RX-API-DMAC10.html)
JP2015512413A5 (cg-RX-API-DMAC10.html)
JP2020122016A5 (cg-RX-API-DMAC10.html)
WO2015057692A1 (en) Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy
JP2024520395A5 (cg-RX-API-DMAC10.html)